cho_logo_symbol_border

Clear Health Pass MDGeneticPro Women’s Health

Improve Care with Comprehensive Women’s Health Solutions

Clear Health Pass MDGeneticPro Women’s Health solution provides accurate and actionable answers about the most common infections of the genital tract. Our Women’s Health panel also allows patients to receive their results in less time than traditional testing methods. This comprehensive panel includes 33 assays for bacterial, fungal, protozoal, and mycoplasma organisms, pathogens and normal flora are included. Clear Health Pass MDGeneticPro Women’s Health is designed to provide fast and accurate results for genital tract infections with just one swab.

A Comprehensive Women’s Health Solution:

  • All Women’s Health Assays (BV/CV/STDs) – from one sample source.
  • Single, routine vaginal swab can be tested for one or all assay panels.

30 Wall St. 8th floor New York, NY 10005

Clear Health Pass as Specifications Developer

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

As a Specification Developer, the Company may also arrange for the manufacturing of devices labeled with another establishment’s
name by a contract manufacturer.

The distribution of collection kits, specimen transport, marketing, test distribution, and actual testing is performed by a high-complexity Clinical Laboratory Improvement Amendments (CLIA) lab.

All testing conducted by the CLIA lab is compliant with the Centers for Medicare and Medicaid Services (CMS) CLIA Lab Amendments Act.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Skip to content